Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:57:58 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Q:SIGY - SIGYN THERAPEUTICS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SIGY - Qnot subscribed5.50    12.80  2.08Apr 18Mar 0515 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-05 09:00U:SIGYNews ReleaseSigyn Therapeutics(TM) to Present at Tomorrow's Emerging Growth Conference
2024-02-21 08:45U:SIGYNews ReleaseSigyn Therapeutics ¢ „ ¢ Announces Filing of 2023 Annual Report on SEC Form 10-K
2024-02-01 18:25U:SIGYNews ReleaseSigyn Therapeutics Completes Reverse Stock Split
2024-01-30 08:45U:SIGYNews ReleaseSigyn Therapeutics Announces Reverse Stock Split
2024-01-04 08:00U:SIGYNews ReleaseSigyn Therapeutics Releases Letter to Shareholders
2023-12-12 08:30U:SIGYNews ReleaseSigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer
2023-11-14 17:12U:SIGYNews ReleaseSigyn Therapeutics Reports Third Quarter 2023 Financial Results
2023-10-04 08:30U:SIGYNews ReleaseSigyn Therapeutics ¢ „ ¢ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity
2023-08-14 16:30U:SIGYNews ReleaseSigyn Therapeutics Reports Second Quarter 2023 Financial Results
2023-07-31 08:35U:SIGYNews ReleaseSigyn Therapeutics to Present at the OTCQB Venture Virtual Investor Conference on August 3rd
2023-05-17 07:00U:SIGYNews ReleaseSigyn Therapeutics Discloses ¢ € œDEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES ¢ €  Patent Submission and Related ImmunePrep ¢ „ ¢ Trademark Application
2023-05-16 07:30U:SIGYNews ReleaseSigyn Therapeutics Reports First Quarter 2023 Financial Results